Immunity to hepatitis A, B ‘remains suboptimal’ in US
Despite years of vaccine availability and recommendation, serologic immunity to hepatitis A and B viruses remains low in the U.S., even among high-risk groups, according to cross-s...
Search fresh public links, source activity, and ready-to-use post angles for Hepatitis B.
Fresh curated links around hepatitis b are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Despite years of vaccine availability and recommendation, serologic immunity to hepatitis A and B viruses remains low in the U.S., even among high-risk groups, according to cross-s...
FRIDAY, Oct. 23, 2026 — Some adults with chronic hepatitis B may now have a path to something today’s treatments rarely deliver — stopping all medication while the virus stays in c...
NASHVILLE, Tenn. — Two doses of hepatitis B virus vaccine with CpG adjuvant may not be sufficient for people with HIV who do not respond to an initial vaccination series, according...
WASHINGTON — A new retrospective cohort study revealed that more than half of early childhood exposures to hepatitis B virus come from household members other than the birth mother...
FRIDAY, Oct. 23, 2026 — Revised federal vaccination guidelines for hepatitis B could leave children at risk of contracting the liver-damaging virus from other family members, a ne...
For the first time, many people living with chronic hepatitis B may have a functi...
Ending routine vaccination for hepatitis B at birth, as the health secretary has recommended, would increase the number of chronic infections by as much as 83 percent, a team of re...
The FDA approved bepirovirsen as the first antisense oligonucleotide for chronic hepatitis B virus infection, alongside existing antiviral therapy for eligible adults without cirrh...
Khi ngưá»i trưởng thà nh nhiá»…m vi rút viêm gan B (HBV), nguy cÆ¡ chuyển thà nh nhiá»…m mạn tÃnh chỉ khoảng 2-5%. Trong khi đó, trẻ sÆ¡ sinh nhiá»…m HBV từ má...
An experimental therapy kept the virus at bay for at least six months. The approach could target other stubborn viruses too. The post Epigenetic Editing Could Wipe Out Chronic Hepa...
GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to make copies of itself and viral proteins. This drug was...
India has reaffirmed its goal of eliminating hepatitis B and C as public health threats by 2030. With millions affected, the focus is shifting to wider screening, vaccination, earl...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.